Our Leadership

The board of directors of PhRMA includes senior leaders representing the world’s top developers of new treatments and cures who are committed to improving health care through innovation and research. The senior executive team at PhRMA works closely with the board of directors to advance policies that ensure continued investment in biopharmaceutical innovation.

Leadership

George Scangos

Chairman of the Board
CEO
Biogen

Read More

Joaquin Duato

Chairman Elect
Executive Vice President and Worldwide Chairman, Pharmaceuticals
Johnson & Johnson

Read More

Joseph Jimenez

Treasurer of the Board
CEO
Novartis Pharmaceuticals Corporation

Read More

 

Board of Directors

Carlos Alban

Executive Vice President, Commercial Operations
AbbVie

Read More

Jeff Aronin

Chairman and CEO
Marathon Pharmaceuticals

Read More

Werner Baumann

Chairman of the Board of Management
Bayer AG

Read More

Robert A. Bradway

Chairman & CEO
Amgen Inc.

Read More

Olivier Brandicourt

Chief Executive Officer
Sanofi

Read More

Giovanni Caforio, M.D

Chief Executive Officer
Bristol-Myers Squibb Company

Read More

William Carson

President & CEO
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Read More

Ivan Cheung

Chairman & CEO
Eisai Inc.

Read More

Bruce C. Cozadd

Chairman and Chief Executive Officer
Jazz Pharmaceuticals plc

Read More

Paul Fonteyne

President & CEO
Boehringer Ingelheim Pharmaceuticals, Inc.

Read More

Ken Frazier

Chairman of the Board & Chief Executive Officer
Merck & Co., Inc.

Read More

Belen Garijo

Member of the Executive Board & CEO
Merck KGaA

Read More

Glenn J. Gormley, MD, PhD

Chairman of the Board, Executive Chairman & President
Daiichi Sankyo, Inc.

Read More

Peter Greenleaf

Chairman and Chief Executive Officer
Sucampo Pharmaceuticals, Inc.

Read More

David Hallal

Chief Executive Officer
Alexion Pharmaceuticals, Inc.

Read More

William K. Heiden

Chief Executive Officer
AMAG Pharmaceuticals, Inc.

Read More

Robert J. Hugin

Executive Chairman
Celgene Corporation

Read More

John C. Lechleiter, Ph.D.

Chairman, President, & CEO
Eli Lilly and Company

Read More

Clive Meanwell, MD, PhD

Chief Executive Officer
The Medicines Company

Read More

Michael A. Narachi

President & Chief Executive Officer
Orexigen Therapeutics, Inc.

Read More

Richard F. Pops

Chairman & CEO
Alkermes plc.

Read More

Ian Read

Chairman of the Board and Chief Executive Officer
Pfizer Inc.

Read More

Jakob Riis

Executive Vice President, North America Operations
Novo Nordisk, Inc.

Read More

James Robinson

President, Americas Operations
Astellas Pharma US, Inc.

Read More

Brenton Saunders

CEO and President
Allergan plc

Read More

Staffan Schuberg

EVP & Global CCO
Lundbeck Inc.

Read More

Ramona Sequeira

President
Takeda Pharmaceuticals USA, Inc.

Read More

Pascal Soriot

Executive Director, Chief Executive Officer
AstraZeneca Pharmaceuticals LP

Read More

Nobuhiko Tamura

Vice Chair & President
Sunovion Pharmaceuticals Inc.

Read More

Mark Timney

Chief Executive Officer
Purdue Pharma L.P.

Read More

Mark Trudeau

President and Chief Executive Officer
Mallinckrodt Pharmaceuticals

Read More

Erez Vigodman

President and Chief Executive Officer
Teva US Specialty Medicines

Read More

Timothy P. Walbert

Chairman, President and Chief Executive Officer
Horizon Pharma

Read More

Sir Andrew Witty

Chief Executive Officer
GlaxoSmithKline

Read More

Senior Executives

Stephen J. Ubl

President and Chief Executive Officer

Read More

William "Bill" Chin, M.D.

Chief Medical Officer and Executive Vice President, Science and Regulatory Affairs

Read More

Robert Zirkelbach

Executive Vice President, Public Affairs

Read More

Paul Aines

Executive Vice President, Administration, and Chief Financial Officer

Read More

Lori M. Reilly, J.D.

Executive Vice President, Policy and Research

Read More

Rodger Currie

Executive Vice President, Advocacy

Read More

James C. Stansel

Executive Vice President & General Counsel

Read More